Developer docs
API playgroundTry for free, no card

Search company profiles

Cytion

Full company profile

uuid000eb7r

Namestring
Cytion
Legal namestring
Cytion GmbH
Websiteurl
cytion.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Cytion GmbH is a Heidelberg-based (Eppelheim, Germany) provider of authenticated biological materials and cell culture services for life sciences research, operating under ISO 9001:2015 quality management. Its core offering is a catalog of more than 1,000 cell lines — spanning human, animal, stem, primary, and reporter-labeled cells — in which every human line undergoes STR profiling and full contamination screening (mycoplasma, bacteria, fungi, viruses), accompanied by a Certificate of Analysis. A specialized line of business is a collection of 272 HLA-typed cell lines with high-resolution NGS typing across eight loci (A, B, C, DRB1, DQA1, DQB1, DPB1, E), targeted at immunological and transplant research. Complementing the catalog are cell culture services (mycoplasma detection, STR authentication, assay-ready cell preparation, cell culture expansion, cell banking, and sample storage) and ancillary media, buffers, supplements, and cell detachment reagents.

The company was founded in 2004 by Dr. Rosemarie Steubing as Cell Lines Service, rebranded to Cytion in 2023, and remains founder-owned under Managing Director Jonathan Steubing. It sells primarily through a self-serve, multi-language e-commerce storefront with regional storefronts across Germany, France, the UK, the US, Canada, and Spain, supported by cold-chain logistics to researchers in 80+ countries, an authorized distributor network, and a US distribution subsidiary (Cell Lines Service LLC, Sioux Falls). A Technology Transfer Program enables research institutions to deposit cell lines into Cytion's distribution network in exchange for revenue share. Customers are split between academic and university research institutions (drug discovery, cancer biology, immunology, vaccine development, virology, gene therapy, neuroscience, toxicology) and pharmaceutical and biotechnology companies requiring regulatory-compliant documentation.

Commercial expansion is currently anchored by an exclusive February 2026 partnership with AsedaSciences, under which Cytion is the sole cell line partner for the 3RnD cloud-based, AI-driven phenotypic screening platform, integrating authenticated cell models into a target-to-cell workflow for early drug safety and toxicity assessment. Pricing is per-vial (approximately €430–€800 per unit depending on line) with separate service-based fees; commercial-use rights require bespoke Supply Agreements beyond the standard MTA. No external funding rounds, IPO, or institutional investors are disclosed, and revenue figures are not publicly reported.

Short descriptiontext

Cytion GmbH is a Heidelberg-based cell biology provider selling 1,000+ STR-authenticated human, animal, stem, primary, and reporter-labeled cell lines plus 272 NGS HLA-typed lines and related culture services to academic and pharmaceutical researchers in 80+ countries via e-commerce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHeidelberg, Germany
HQ citystring
Heidelberg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
authenticated cell lines, cell culture reagents, primary cell products, HLA typing services, mycoplasma detection testing
Industry1 code
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Cell Culture Products
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Cell Line and Primary Cell Product Sales
TypeOne Time License
Description

Cytion generates revenue primarily through direct product sales of authenticated cell lines (human, animal, stem), primary cells, and reporter-labeled cells via its e-commerce platform. Products are priced per vial/unit with pricing ranging from €430 to €800+ depending on the cell line. Orders are fulfilled globally with cold-chain logistics.

cytion.com
2Media & Reagents
TypeOne Time License
Description

Sale of cell culture media, buffers, supplements, and cell detachment reagents to support cell culture workflows.

cytion.com
3Cell Culture Services
TypeProfessional Services
Description

Fee-for-service offerings including mycoplasma detection testing, cell line STR authentication, sample storage, assay-ready cell preparation, cell culture expansion, and cell banking services.

cytion.com
4Technology Transfer / Revenue Share
TypeLicensing Royalties
Description

Cytion accepts deposited cell lines from research institutions (universities, hospitals, research centers) under its Technology Transfer Program, distributing them globally and sharing revenue with the depositing institution.

cytion.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details3 tiers
1Per-vial unit pricing for cell lines
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Cell line products sold as individual vials with per-unit pricing. Examples: HEK293 suspension-adapted €500/vial, BV2 €650/vial, HT22 €800/vial, MCF10A €550/vial, Vero E6 €430/vial. Academic and commercial pricing differs; commercial use requires separate licensing.

cytion.com
2Service-based pricing for cell culture services
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Services include mycoplasma testing, STR authentication, sample storage, assay-ready cell service, cell culture expansion, and cell banking, billed per service request or via subscription arrangements for ongoing needs.

cytion.com
3Standard MTA for internal research use
ModelOtherBilling cadencePay-as-you-go
Notes

Standard Material Transfer Agreement (MTA) governs supply of cell lines for non-commercial, permitted internal research use. Commercial rights, further transfers, and regulated applications require separate written Supply Agreements with Cytion. Prices quoted are net prices plus statutory VAT.

cytion.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Cytion is a cell culture provider producing and distributing authenticated human and animal cell lines, primary cells, stem cells, and reporter-labeled cells, complemented by culture media, buffers, supplements, and cell detachment reagents. The company also offers professional cell culture services including mycoplasma detection testing, STR-based cell line authentication, assay-ready cell preparation, cell culture expansion, cell banking, and sample storage. All offerings are produced under ISO 9001:2015 quality management and shipped globally with cold-chain logistics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 60-day viability guarantee on all cell products from shipment date
+3 more records
Product overview1 text field

Cytion is a cell biology company offering a comprehensive portfolio of authenticated biological materials and cell culture services. The core offering includes over 1,000 authenticated cell lines (human, animal, stem, and reporter-labeled), primary cells, and media/reagents. These are complemented by professional cell culture services including mycoplasma testing, STR authentication, assay-ready cell preparation, cell banking, and sample storage. A specialized offering includes 272 HLA-typed cell lines with high-resolution NGS typing for immunological research. The company operates under ISO 9001:2015 certification and serves researchers in over 80 countries.

Product and service14 records
1Cell Lines (Human and Animal)
CategoryCore Product
Description

Authenticated human and animal cell lines that are STR-profiled and screened for mycoplasma, viruses, bacteria, and fungi. The portfolio spans over 1,000 cell lines across human cells, animal cells, stem cells, and reporter-labeled cells, sold per vial at €430–€800+ depending on the line.

2Primary Cells
CategoryCore Product
Description

High-quality primary cells including fibroblasts, HUVEC, and oral cells for research applications requiring cells isolated directly from tissue without extended passaging.

3Stem Cells
CategoryCore Product
Description

Stem cell products including iPSCs and adult stem cells for research applications spanning developmental biology, regenerative medicine studies, and disease modeling.

4Reporter-Labeled Cells
CategoryCore Product
Description

Engineered cell lines with reporter labels (e.g., fluorescent or luminescent markers) for use in various research applications including gene expression studies, signaling pathway analysis, and high-content screening assays.

5HLA-Typed Cell Lines
CategorySpecialized Product
Description

Authenticated cell lines with high-resolution Next-Generation Sequencing (NGS) HLA typing across eight loci (Class I: A, B, C; Class II: DRB1, DQA1, DQB1, DPB1; non-classical: E). A collection of 272 HLA-typed cell lines designed for immunological and transplant research.

6Cell Culture Media
CategoryCore Product
Description

Culture media formulations designed for optimal cell growth and maintenance of the various cell lines offered, supporting routine cell culture workflows.

7Buffer and Supplements
CategoryCore Product
Description

Buffer solutions and supplements to support cell culture workflows, including pH-stabilizing buffers and growth-promoting supplements.

8Cell Detachment Reagents
CategoryCore Product
Description

Reagents and solutions for cell detachment from culture surfaces, including enzymatic and non-enzymatic dissociation reagents for cell passaging and harvesting.

9Mycoplasma Detection Test
CategoryService
Description

Service using PCR-based and culture-based assays to confirm the absence of mycoplasma contamination in customer cell lines prior to release or use in downstream applications.

10Cell Line Authentication (STR)
CategoryService
Description

Short Tandem Repeat (STR) profiling service to validate cell line identity and ensure traceability, addressing misidentification concerns that affect research reproducibility.

11Assay-Ready Cell Service
CategoryService
Description

Professional preparation of cells ready for immediate assay implementation, reducing researcher prep time by delivering cells in assay-ready formats.

12Cell Culture Expansion
CategoryService
Description

Professional cell culture expansion services to scale up cell cultures to the quantities required by researchers or for downstream bioprocess applications.

13Cell Banking
CategoryService
Description

Secure cryogenic storage and banking services for valuable cell lines, preserving them under controlled conditions for long-term research continuity.

14Sample Storage Service
CategoryService
Description

Long-term storage solutions for biological samples under controlled environmental conditions, supporting research continuity and sample preservation.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-02-17
Description

Exclusive partnership making Cytion the sole cell line partner for AsedaSciences' 3RnD cloud platform. Combines Cytion's authenticated human cell models with AsedaSciences' AI-driven phenotypic screening to help researchers identify compound safety and toxicity risks earlier in drug development. The collaboration introduces an integrated target-to-cell workflow allowing scientists to search cell lines by biological target and proceed directly to ordering, streamlining experimental setup. The partnership rolls out in phases with pilot users to refine the target-to-cell discovery experience.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The dominant global biorepository of authenticated cell lines, microorganisms, and biological materials for research. Most direct competitor to Cytion, with deeper catalog and brand recognition among academic and pharma researchers.

TypeDirect peer
Description

German cell line and microorganism repository offering authenticated cell lines for research. Most comparable European peer to Cytion given geographic proximity and overlapping catalog, including many cell lines served to academic and pharma customers.

TypeDirect peer
Description

US-based non-profit biorepository distributing authenticated human cell lines and DNA samples for research. Comparable in mission and product offering (authenticated cell lines, HLA-typed lines, sample storage) to Cytion.

4ECACC (European Collection of Authenticated Cell Cultures)
TypeDirect peer
Description

Operated by Culture Collections (UK Health Security Agency), ECACC distributes authenticated cell lines primarily for academic and pharma research. Direct peer serving overlapping European research customers.

TypeBroad incumbent
Description

Largest life sciences tools supplier, offering cell lines and cell culture media/reagents as part of the broader Gibco portfolio. Competes with Cytion on cell lines but operates at much larger scale across many product categories.

6Merck KGaA / Sigma-Aldrich
TypeBroad incumbent
Description

Global life sciences supplier distributing cell lines (via Sigma-Aldrich) alongside a vast catalog of reagents, media, and lab consumables. Overlaps with Cytion on cell line distribution but competes primarily as a one-stop-shop alternative.

7JCRB Cell Bank (National Institutes of Biomedical Innovation)
TypeRegional player
Description

Japanese national cell line repository distributing authenticated cell lines to researchers in Asia. Comparable in offering (authenticated cell lines, HLA data) but serves primarily Asian markets rather than competing directly with Cytion in Europe/Americas.

TypeBroad incumbent
Description

Major cell and gene therapy CDMO offering cell line engineering, banking, and manufacturing services. Broadly comparable to Cytion on cell culture services but operates at significantly larger scale and focuses on clinical/commercial manufacturing.

9Cell Bank Australia (Children's Medical Research Institute)
TypeRegional player
Description

Australian non-profit cell line repository serving research customers in Australia and the Asia-Pacific region. Comparable offering (authenticated cell lines, cell banking services) with regional rather than direct competition with Cytion.

10XCell Science
TypeEmerging player
Description

Specialized provider of iPSC-derived neuronal and glial cell models for neuroscience research. Emerging peer offering higher-value differentiated cell models — adjacent to Cytion's stem cell and specialty cell line portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cytion

Cell Culture Productscytion.com

Cytion GmbH is a Heidelberg-based cell biology provider selling 1,000+ STR-authenticated human, animal, stem, primary, and reporter-labeled cell lines plus 272 NGS HLA-typed lines and related culture services to academic and pharmaceutical researchers in 80+ countries via e-commerce.

What Cytion does

Cytion GmbH is a Heidelberg-based (Eppelheim, Germany) provider of authenticated biological materials and cell culture services for life sciences research, operating under ISO 9001:2015 quality management. Its core offering is a catalog of more than 1,000 cell lines — spanning human, animal, stem, primary, and reporter-labeled cells — in which every human line undergoes STR profiling and full contamination screening (mycoplasma, bacteria, fungi, viruses), accompanied by a Certificate of Analysis. A specialized line of business is a collection of 272 HLA-typed cell lines with high-resolution NGS typing across eight loci (A, B, C, DRB1, DQA1, DQB1, DPB1, E), targeted at immunological and transplant research. Complementing the catalog are cell culture services (mycoplasma detection, STR authentication, assay-ready cell preparation, cell culture expansion, cell banking, and sample storage) and ancillary media, buffers, supplements, and cell detachment reagents.

The company was founded in 2004 by Dr. Rosemarie Steubing as Cell Lines Service, rebranded to Cytion in 2023, and remains founder-owned under Managing Director Jonathan Steubing. It sells primarily through a self-serve, multi-language e-commerce storefront with regional storefronts across Germany, France, the UK, the US, Canada, and Spain, supported by cold-chain logistics to researchers in 80+ countries, an authorized distributor network, and a US distribution subsidiary (Cell Lines Service LLC, Sioux Falls). A Technology Transfer Program enables research institutions to deposit cell lines into Cytion's distribution network in exchange for revenue share. Customers are split between academic and university research institutions (drug discovery, cancer biology, immunology, vaccine development, virology, gene therapy, neuroscience, toxicology) and pharmaceutical and biotechnology companies requiring regulatory-compliant documentation.

Commercial expansion is currently anchored by an exclusive February 2026 partnership with AsedaSciences, under which Cytion is the sole cell line partner for the 3RnD cloud-based, AI-driven phenotypic screening platform, integrating authenticated cell models into a target-to-cell workflow for early drug safety and toxicity assessment. Pricing is per-vial (approximately €430–€800 per unit depending on line) with separate service-based fees; commercial-use rights require bespoke Supply Agreements beyond the standard MTA. No external funding rounds, IPO, or institutional investors are disclosed, and revenue figures are not publicly reported.

Cytion firmographics

Firmographics
Name
Cytion
Legal name
Cytion GmbH
Website
https://cytion.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Cytion GmbH is a Heidelberg-based cell biology provider selling 1,000+ STR-authenticated human, animal, stem, primary, and reporter-labeled cell lines plus 272 NGS HLA-typed lines and related culture services to academic and pharmaceutical researchers in 80+ countries via e-commerce.
Ownership category
akta.pro rank

Cytion industry classification

Industry
Product category
Cell Culture Products
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Authenticated cell lines
  • Cell culture reagents
  • Primary cell products
  • HLA typing services
  • Mycoplasma detection testing

Where Cytion is headquartered

Location

Headquarters

HQ city
Heidelberg
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Cytion business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Cell Line and Primary Cell Product Sales: Cytion generates revenue primarily through direct product sales of authenticated cell lines (human, animal, stem), primary cells, and reporter-labeled cells via its e-commerce platform. Products are priced per vial/unit with pricing ranging from €430 to €800+ depending on the cell line. Orders are fulfilled globally with cold-chain logistics.
  2. Media & Reagents: Sale of cell culture media, buffers, supplements, and cell detachment reagents to support cell culture workflows.
  3. Cell Culture Services: Fee-for-service offerings including mycoplasma detection testing, cell line STR authentication, sample storage, assay-ready cell preparation, cell culture expansion, and cell banking services.
  4. Technology Transfer / Revenue Share: Cytion accepts deposited cell lines from research institutions (universities, hospitals, research centers) under its Technology Transfer Program, distributing them globally and sharing revenue with the depositing institution.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPer-vial unit pricing for cell lines
SubscriptionMulti-year contractService-based pricing for cell culture services
OtherPay-as-you-goStandard MTA for internal research use

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Cytion product offering

Product offering

Core offering

Cytion is a cell culture provider producing and distributing authenticated human and animal cell lines, primary cells, stem cells, and reporter-labeled cells, complemented by culture media, buffers, supplements, and cell detachment reagents. The company also offers professional cell culture services including mycoplasma detection testing, STR-based cell line authentication, assay-ready cell preparation, cell culture expansion, cell banking, and sample storage. All offerings are produced under ISO 9001:2015 quality management and shipped globally with cold-chain logistics.

Product overview

Cytion is a cell biology company offering a comprehensive portfolio of authenticated biological materials and cell culture services. The core offering includes over 1,000 authenticated cell lines (human, animal, stem, and reporter-labeled), primary cells, and media/reagents. These are complemented by professional cell culture services including mycoplasma testing, STR authentication, assay-ready cell preparation, cell banking, and sample storage. A specialized offering includes 272 HLA-typed cell lines with high-resolution NGS typing for immunological research. The company operates under ISO 9001:2015 certification and serves researchers in over 80 countries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cell Lines (Human and Animal) Authenticated human and animal cell lines that are STR-profiled and screened for mycoplasma, viruses, bacteria, and fungi. The portfolio spans over 1,000 cell lines across human cells, animal cells, stem cells, and reporter-labeled cells, sold per vial at €430–€800+ depending on the line.
  • Primary Cells High-quality primary cells including fibroblasts, HUVEC, and oral cells for research applications requiring cells isolated directly from tissue without extended passaging.
  • Stem Cells Stem cell products including iPSCs and adult stem cells for research applications spanning developmental biology, regenerative medicine studies, and disease modeling.
  • Reporter-Labeled Cells Engineered cell lines with reporter labels (e.g., fluorescent or luminescent markers) for use in various research applications including gene expression studies, signaling pathway analysis, and high-content screening assays.
  • HLA-Typed Cell Lines Authenticated cell lines with high-resolution Next-Generation Sequencing (NGS) HLA typing across eight loci (Class I: A, B, C; Class II: DRB1, DQA1, DQB1, DPB1; non-classical: E). A collection of 272 HLA-typed cell lines designed for immunological and transplant research.
  • Cell Culture Media Culture media formulations designed for optimal cell growth and maintenance of the various cell lines offered, supporting routine cell culture workflows.
  • Buffer and Supplements Buffer solutions and supplements to support cell culture workflows, including pH-stabilizing buffers and growth-promoting supplements.
  • Cell Detachment Reagents Reagents and solutions for cell detachment from culture surfaces, including enzymatic and non-enzymatic dissociation reagents for cell passaging and harvesting.
  • Mycoplasma Detection Test Service using PCR-based and culture-based assays to confirm the absence of mycoplasma contamination in customer cell lines prior to release or use in downstream applications.
  • Cell Line Authentication (STR) Short Tandem Repeat (STR) profiling service to validate cell line identity and ensure traceability, addressing misidentification concerns that affect research reproducibility.
  • Assay-Ready Cell Service Professional preparation of cells ready for immediate assay implementation, reducing researcher prep time by delivering cells in assay-ready formats.
  • Cell Culture Expansion Professional cell culture expansion services to scale up cell cultures to the quantities required by researchers or for downstream bioprocess applications.
  • Cell Banking Secure cryogenic storage and banking services for valuable cell lines, preserving them under controlled conditions for long-term research continuity.
  • Sample Storage Service Long-term storage solutions for biological samples under controlled environmental conditions, supporting research continuity and sample preservation.

Quantifiable outcome

  • 60-day viability guarantee on all cell products from shipment date
  • +3 more outcomes

Companies that use Cytion

Customer profile

Segments4 records

Ideal customer profiles2 records

Cytion technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Cytion partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AsedaSciencesflagshipStrategic or Co-development Partner · 17 February 2026Exclusive partnership making Cytion the sole cell line partner for AsedaSciences' 3RnD cloud platform. Combines Cytion's authenticated human cell models with AsedaSciences' AI-driven phenotypic screening to help researchers identify compound safety and toxicity risks earlier in drug development. The collaboration introduces an integrated target-to-cell workflow allowing scientists to search cell lines by biological target and proceed directly to ordering, streamlining experimental setup. The partnership rolls out in phases with pilot users to refine the target-to-cell discovery experience.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Cytion competitors and assessment

Company assessment

Direct peers

  • ATCC (American Type Culture Collection): The dominant global biorepository of authenticated cell lines, microorganisms, and biological materials for research. Most direct competitor to Cytion, with deeper catalog and brand recognition among academic and pharma researchers.
  • DSMZ (Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures): German cell line and microorganism repository offering authenticated cell lines for research. Most comparable European peer to Cytion given geographic proximity and overlapping catalog, including many cell lines served to academic and pharma customers.
  • Coriell Institute for Medical Research: US-based non-profit biorepository distributing authenticated human cell lines and DNA samples for research. Comparable in mission and product offering (authenticated cell lines, HLA-typed lines, sample storage) to Cytion.
  • ECACC (European Collection of Authenticated Cell Cultures): Operated by Culture Collections (UK Health Security Agency), ECACC distributes authenticated cell lines primarily for academic and pharma research. Direct peer serving overlapping European research customers.

Broad incumbents

  • Thermo Fisher Scientific (Gibco): Largest life sciences tools supplier, offering cell lines and cell culture media/reagents as part of the broader Gibco portfolio. Competes with Cytion on cell lines but operates at much larger scale across many product categories.
  • Merck KGaA / Sigma-Aldrich: Global life sciences supplier distributing cell lines (via Sigma-Aldrich) alongside a vast catalog of reagents, media, and lab consumables. Overlaps with Cytion on cell line distribution but competes primarily as a one-stop-shop alternative.
  • Lonza: Major cell and gene therapy CDMO offering cell line engineering, banking, and manufacturing services. Broadly comparable to Cytion on cell culture services but operates at significantly larger scale and focuses on clinical/commercial manufacturing.

Regional players

  • JCRB Cell Bank (National Institutes of Biomedical Innovation): Japanese national cell line repository distributing authenticated cell lines to researchers in Asia. Comparable in offering (authenticated cell lines, HLA data) but serves primarily Asian markets rather than competing directly with Cytion in Europe/Americas.
  • Cell Bank Australia (Children's Medical Research Institute): Australian non-profit cell line repository serving research customers in Australia and the Asia-Pacific region. Comparable offering (authenticated cell lines, cell banking services) with regional rather than direct competition with Cytion.

Emerging players

  • XCell Science: Specialized provider of iPSC-derived neuronal and glial cell models for neuroscience research. Emerging peer offering higher-value differentiated cell models — adjacent to Cytion's stem cell and specialty cell line portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cytion compliance and trust

Trust signal

Compliance3 records

Cytion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cytion leadership team

Management profile

Number of profiles

Profiles2 records

Cytion subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cytion funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cytion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cytion

What does Cytion do?

Cytion is a cell culture provider producing and distributing authenticated human and animal cell lines, primary cells, stem cells, and reporter-labeled cells, complemented by culture media, buffers, supplements, and cell detachment reagents. The company also offers professional cell culture services including mycoplasma detection testing, STR-based cell line authentication, assay-ready cell preparation, cell culture expansion, cell banking, and sample storage. All offerings are produced under ISO 9001:2015 quality management and shipped globally with cold-chain logistics.

Is Cytion a public or private company?

Cytion is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cytion founded?

Cytion was founded in 2004. It employs 11 to 50 people.

Where is Cytion based?

Cytion is headquartered in Heidelberg, Germany, in the Europe region.

How does Cytion make money?

Four revenue lines are on record. Cell Line and Primary Cell Product Sales are the primary driver. The others are media & Reagents, cell Culture Services and technology Transfer / Revenue Share.

Who are Cytion's main competitors?

Direct peers on record are ATCC (American Type Culture Collection), DSMZ (Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures), Coriell Institute for Medical Research and ECACC (European Collection of Authenticated Cell Cultures). Broad incumbents are Thermo Fisher Scientific (Gibco), Merck KGaA / Sigma-Aldrich and Lonza. Regional players are JCRB Cell Bank (National Institutes of Biomedical Innovation) and Cell Bank Australia (Children's Medical Research Institute). XCell Science is listed as an emerging player.

Does Cytion have an API?

No public API is recorded for Cytion.

What industry is Cytion in?

Cytion's product category is Cell Culture Products. Its primary akta.pro industry code is HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals